Submitted:
20 December 2024
Posted:
24 December 2024
You are already at the latest version
Abstract
Background: Affective temperaments can be considered the subclinical manifestations of affective and stress-related disorders, which could have a relationship with many chronic diseases. The purpose of this study was to explore the influence of affective temperament traits on disease-specific quality of life in patients with ulcerative colitis (UC) and Crohn’s disease (CD), two types of inflammatory bowel disease (IBD). Methods: The study included 116 patients with IBD - 61 with UC and 55 with CD, with mean age 43 years, in remission, without serious mental or medical co-morbidities. The patients completed the Temperament Evaluation of the Memphis Pisa Paris San Diego-Auto-questionnaire (TEMPS-A), which is the 110-item self-reported assessment for five dimensions of temperament: depressive, cyclothymic, hyperthymic, irritable and anxious, already validated in Poland. For comprehensive assessment of the health-related quality of life (HRQoL), the Inflammatory Bowel Disease Questionnaire (IBDQ) was applied. Results: Mean HRQoL in IBD patients was poor and mean IBDQ scores were 145, despite clinical remission. A significant negative correlation was found between HRQoL in all the IBDQ domains and TEMPS-A traits: D (p<0.001), C (p<0.01), I (p<0.05) and A (p<0.001). No significant correlation between hyperthymic temperament and IBDQ scores was found. Conclusions: Poor quality of life in IBD could be associated with affective temperament. Affective temperament traits should be taken into account when identifying patients at riskof worse IBD course and further introducing the personalized therapy.
Keywords:
1. Introduction
2. Materials and Methods
Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Conflicts of Interest
Appendix A
| TEMPS -D | Total | |||||||
| <0.5 | >=0.5 | |||||||
| N | % | N | % | N | % | |||
| group | CD | 40 | 50.0 | 12 | 40.0 | 52 | 47.3 | 0.3495 |
| UC | 40 | 50.0 | 18 | 60.0 | 58 | 52.7 | ||
| Gender | 0 | 40 | 50.0 | 17 | 56.7 | 57 | 51.8 | 0.5331 |
| 1 | 40 | 50.0 | 13 | 43.3 | 53 | 48.2 | ||
| ASA | 0 | 9 | 11.3 | 2 | 6.7 | 11 | 10.0 | 0.4755 |
| 1 | 71 | 88.8 | 28 | 93.3 | 99 | 90.0 | ||
| AZT | 0 | 51 | 63.8 | 26 | 86.7 | 77 | 70.0 | 0.0195 |
| 1 | 29 | 36.3 | 4 | 13.3 | 33 | 30.0 | ||
| Anty-TNF | 0 | 53 | 66.3 | 25 | 83.3 | 78 | 70.9 | 0.0789 |
| 1 | 27 | 33.8 | 5 | 16.7 | 32 | 29.1 | ||
| surgery | 0 | 59 | 73.8 | 23 | 76.7 | 82 | 74.5 | 0.7545 |
| 1 | 21 | 26.3 | 7 | 23.3 | 28 | 25.5 | ||
| TEMPS -C | P | |||||
| <0.5 | >=0.5 | |||||
| N | % | N | % | |||
| group | CD | 30 | 44.1 | 22 | 52.4 | 0.3990 |
| UC | 38 | 55.9 | 20 | 47.6 | ||
| gender | 0 | 33 | 48.5 | 24 | 57.1 | 0.3797 |
| 1 | 35 | 51.5 | 18 | 42.9 | ||
| 5-ASA | 0 | 5 | 7.4 | 6 | 14.3 | 0.2390 |
| 1 | 63 | 92.6 | 36 | 85.7 | ||
| AZT | 0 | 46 | 67.6 | 31 | 73.8 | 0.4932 |
| 1 | 22 | 32.4 | 11 | 26.2 | ||
| Anty-TNF | 0 | 53 | 77.9 | 25 | 59.5 | 0.0388 |
| 1 | 15 | 22.1 | 17 | 40.5 | ||
| surgery | 0 | 52 | 76.5 | 30 | 71.4 | 0.5553 |
| 1 | 16 | 23.5 | 12 | 28.6 | ||
| TEMPS – H | P | |||||
| <0.5 | >=0.5 | |||||
| N | % | N | % | |||
| group | CD | 31 | 44.9 | 21 | 51.2 | 0.5227 |
| UC | 38 | 55.1 | 20 | 48.8 | ||
| gender | 0 | 36 | 52.2 | 21 | 51.2 | 0.9228 |
| 1 | 33 | 47.8 | 20 | 48.8 | ||
| 5-ASA | 0 | 8 | 11.6 | 3 | 7.3 | 0.4697 |
| 1 | 61 | 88.4 | 38 | 92.7 | ||
| AZT | 0 | 52 | 75.4 | 25 | 61.0 | 0.1114 |
| 1 | 17 | 24.6 | 16 | 39.0 | ||
| Anty-TNF | 0 | 53 | 76.8 | 25 | 61.0 | 0.0770 |
| 1 | 16 | 23.2 | 16 | 39.0 | ||
| surgery | 0 | 51 | 73.9 | 31 | 75.6 | 0.8434 |
| 1 | 18 | 26.1 | 10 | 24.4 |
| TEMPS – I | P | |||||
| <0.5 | >=0.5 | |||||
| N | % | N | % | |||
| group | CD | 44 | 43.6 | 8 | 88.9 | 0.0091 |
| UC | 57 | 56.4 | 1 | 11.1 | ||
| gender | 0 | 53 | 52.5 | 4 | 44.4 | 0.6441 |
| 5-ASA | 0 | 9 | 8.9 | 2 | 22.2 | 0.2021 |
| 1 | 92 | 91.1 | 7 | 77.8 | ||
| AZT | 0 | 71 | 70.3 | 6 | 66.7 | 0.8199 |
| 1 | 30 | 29.7 | 3 | 33.3 | ||
| Anty-TNF | 0 | 73 | 72.3 | 5 | 55.6 | 0.2899 |
| 1 | 28 | 27.7 | 4 | 44.4 | ||
| surgery | 0 | 76 | 75.2 | 6 | 66.7 | 0.5712 |
| 1 | 25 | 24.8 | 3 | 33.3 | ||
| TEMPS – A | P | |||||
| <0.5 | >=0.5 | |||||
| N | % | N | % | |||
| group | CD | 34 | 46.6 | 18 | 48.6 | 0.8370 |
| UC | 39 | 53.4 | 19 | 51.4 | ||
| gender | 0 | 32 | 43.8 | 25 | 67.6 | 0.0186 |
| 1 | 41 | 56.2 | 12 | 32.4 | ||
| 5-ASA | 0 | 7 | 9.6 | 4 | 10.8 | 0.8401 |
| 1 | 66 | 90.4 | 33 | 89.2 | ||
| AZT | 0 | 50 | 68.5 | 27 | 73.0 | 0.6281 |
| 1 | 23 | 31.5 | 10 | 27.0 | ||
| Anty-TNF | 0 | 53 | 72.6 | 25 | 67.6 | 0.5828 |
| 1 | 20 | 27.4 | 12 | 32.4 | ||
| surgery | 0 | 54 | 74.0 | 28 | 75.7 | 0.8464 |
| 1 | 19 | 26.0 | 9 | 24.3 |
| TEMPS-D | ||||
| <0.5 | 0.5-0.7 | |||
| Mean | Standard Deviation | Mean | Standard Deviation | |
| age | 42.81 | 16.45 | 44.30 | 13.48 |
| BMI | 23.83 | 4.60 | 23.87 | 4.38 |
| p>0.5 for age and BMI. | ||||
| TEMPS-C | ||||
| <0.5 | 0.5-0.7 | |||
| Mean | Standard Deviation | Mean | Standard Deviation | |
| age | 43.73 | 16.31 | 42.39 | 14.63 |
| BMI | 24.18 | 4.77 | 23.29 | 4.09 |
| p>0.5 for age and BMI | ||||
| TEMPS-H | ||||
| <0.5 | 0.5-0.7 | |||
| Mean | Standard Deviation | Mean | Standard Deviation | |
| age | 43.96 | 14.92 | 41.98 | 16.90 |
| BMI | 23.57 | 4.54 | 24.29 | 4.50 |
| p>0.5 for age and BMI | ||||
| TEMPS-I | ||||
| <0.5 | 0.5-0.7 | |||
| Mean | Standard Deviation | Mean | Standard Deviation | |
| age | 43.27 | 15.83 | 42.63 | 13.84 |
| BMI | 23.81 | 4.52 | 24.11 | 4.73 |
| p>0.5 for age and BMI | ||||
| TEMPS-A | ||||
| <0.5 | 0.5-0.7 | |||
| Mean | Standard Deviation | Mean | Standard Deviation | |
| age | 42.24 | 16.28 | 45.19 | 14.28 |
| BMI | 23.85 | 4.76 | 23.81 | 4.06 |
| p>0.5 for age and BMI | ||||
References
- Chaparro, M.; Garr, A.; Núñez Ortiz, A. 1. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J Clin Med. 2021, 10, 2885. [Google Scholar] [CrossRef]
- Drossman, D.A.; Leserman, J.; Li, Z.M.; Mitchell, C.M.; Zagami, E.A.; Patrick, D.L. The rating form of IBD patient concerns: a new measure of health status. Psychosom. Med. 1991, 53, 701–712. [Google Scholar] [CrossRef] [PubMed]
- Mokrowiecka, A.; Pinkowski, D.; Malecka-Panas, E.; Johnson, C.D. Clinical, emotional and social factors associated with quality of life in chronic pancreatitis. Pancreatology. 2010, 10, 39–46. [Google Scholar] [CrossRef]
- Turnbull, G.K.; Vallis, M.T. Quality of life in inflammatory bowel disease: the interaction of disease activity with psychosocial function. Am. J. Gastroenterol. 1995, 90, 1450–1454. [Google Scholar] [PubMed]
- Rubin, D.T.; Dubinsky, M.C.; Panaccione, R.; Siegel, C.A.; Binion, D.G.; Kane, S.V.; Hopper, J. The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey. Dig. Dis. Sci. 2010, 55, 1044–52. [Google Scholar] [CrossRef]
- Bernklev, T.; Jahnsen, J.; Lygren, I.; Henriksen, M.; Vatn, M.; Moum, B. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm. Bowel. Dis. 2005, 11, 909–918. [Google Scholar] [CrossRef] [PubMed]
- Bernklev, T.; Jahnsen, J.; Henriksen, M.; Lygren, I.; Aadland, E.; Sauar, J.; Schulz, T.; Stray, N.; Vatn, M.; Moum, B. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm. Bowel. Dis. 2006, 12, 402–412. [Google Scholar] [CrossRef]
- Hoivik, M.L.; Moum, B.; Solberg, I.C.; Cvancarova, M.; Hoie, O.; Vatn, M.H.; Bernklev, T. , for the IBSEN Study Group. Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: Results from the IBSEN study. Inflamm. Bowel. Dis. 2011. [Google Scholar] [CrossRef]
- Mokrowiecka, A.; Jurek, K.; Pińkowski, D.; Małecka-Panas, E. The comparison of Health-Related Quality of Life (HRQL) in patients with GERD, peptic ulcer disease and ulcerative colitis. Adv. Med. Sci. 2006, 51, 142–147. [Google Scholar] [PubMed]
- Tanaka, M.; Kazuma, K. Ulcerative colitis: factors affecting difficulties of life and psychological well being of patients in remission. J. Clin. Nurs. 2005, 14, 65–73. [Google Scholar] [CrossRef] [PubMed]
- Taft, T.H.; Keefer, L.; Leonhard, C.; Nealon-Woods, M. Impact of perceived stigma on inflammatory bowel disease patient outcomes. Inflamm. Bowel. Dis. 2009, 15, 1224–32. [Google Scholar] [CrossRef] [PubMed]
- Jäghult, S.; Saboonchi, F.; Johansson, U.B.; Wredling, R.; Kapraali, M. Identifying predictors of low health-related quality of life among patients with inflammatory bowel disease: comparison between Crohn's disease and ulcerative colitis with disease duration. J. Clin. Nurs. 2011, 20, 1578–1587. [Google Scholar] [CrossRef] [PubMed]
- Loftus, E.V. Jr; Guérin, A.; Yu, A.P.; Wu, E.Q.; Yang, M.; Chao, J.; Mulani, P.M. Increased risks of developing anxiety and depression in young patients with Crohn's disease. Am. J. Gastroenterol. 2011, 106, 1670–1677. [Google Scholar] [CrossRef] [PubMed]
- Meder, A.; Świątkowski, M.; Meder, G.; Koza, J. Quality of life and coexisting anxiety-depressive disorders in patients with inflammatory bowel disease during relapse and a further 11 months observation. Gastroenterol. Pol. 2010, 17, 273–279. [Google Scholar]
- Tribbick, D.; Salzberg, M.; Ftanou, M.; Connell, W.R.; Macrae, F.; Kamm, M.A.; Bates, G.W.; Cunningham, G.; Austin, D.W.; Knowles, S.R. Prevalence of mental health disorders in inflammatory bowel disease: an Australian outpatient cohort. Clin. Exp. Gastroenterol. 2015, 17, 197–204. [Google Scholar] [CrossRef]
- Mikocka-Walus, A.; Massuger, W.; Knowles, S.R.; Moore, G.T.; Buckton, S.; Connell, W.; Pavli, P.; Raven, L.; Andrews, J.M. Psychological distress is highly prevalent in inflammatory bowel disease: A survey of psychological needs and attitudes. JGH. Open. 2019, 4, 166–171. [Google Scholar] [CrossRef]
- Mikocka-Walus, A.; Hanlon, I.; Dober, M.; Emerson, C.; Beswick, L.; Selinger, C.; Taylor, J.; Olive, L.; Evans, S.; Hewitt, C. Lived experience in people with inflammatory bowel disease and comorbid anxiety and depression in the United Kingdom and Australia. J. Health. Psychol. 2020, 1359105320911427. [Google Scholar] [CrossRef] [PubMed]
- Nemcsik, J.; Vecsey-Nagy, M.; Szilveszter, B.; Kolossváry, M.; Karády, J.; László, A.; Kőrösi, B.; Nemcsik-Bencze, Z.; Gonda, X.; Merkely, B.; Rihmer, Z.; Maurovich-Horvat, P. Inverse association between hyperthymic affective temperament and coronary atherosclerosis: A coronary computed tomography angiography study. J. Psychosom. Res. 2017, 103, 108–112. [Google Scholar] [CrossRef] [PubMed]
- Rihmer, Z.; Akiskal, K.K.; Rihmer, A.; Akiskal, H.S. Current research on affective temperaments, Curr. Opin. Psychiatry. 2010, 23, 12–18. [Google Scholar] [CrossRef]
- Rovai, L.; Maremmani, A.G.; Rugani, F.; Bacciardi, S.; Pacini, M.; Dell'Osso, L.; Akiskal, H.S.; Maremmani, I. Do Akiskal & Mallya's affective temperaments belong to the domain of pathology or to that of normality? Eur. Rev. Med. Pharmacol. Sci. 2013, Review. [Google Scholar] [PubMed]
- Laszlo, A.; Tabak, B.; Korosi, D.; Eorsi, P.; Torzsa, O.; Cseprekal, O.; Tislér, A.; Reusz, G.; Nemcsik-Bencze, Z.; Gonda, X.; Rihmer, Z.; Nemcsik, J. Association of affective temperaments with blood pressure and arterial stiffness in hypertensive patients: a cross-sectional study, BMC Cardiovasc. Disord. 2016, 16, 158. [Google Scholar]
- Eory, A.; Rozsa, S.; Torzsa, P.; Kalabay, L.; Gonda, X.; Rihmer, Z. Affective temperaments contribute to cardiac complications in hypertension independently of depression. Psychother. Psychosom. 2014, 83, 187–189. [Google Scholar] [CrossRef] [PubMed]
- Marek, L.; Placek, W.; Borkowska, A. Zaburzenia funkcji poznawczych i temperament afektywny u pacjentów z łuszczycą. Przegl. Dermatolog. 2011, 98, 483–490. [Google Scholar]
- Borkowska, A.; Bieliński, M.; Szczęsny, W.; Szwed, K.; Tomaszewska, M.; Kałwa, A.; Lesiewska, N.; Junik, R.; Gołębiewski, M.; Sikora, M.; Tretyn, A.; Akiskal, K.; Akiskal, H. Effect of the 5-HTTLPR polymorphism on affective temperament, depression and body mass index in obesity. J. Affect. Disord. 2015, 184, 193–197. [Google Scholar] [CrossRef] [PubMed]
- Gois, C.; Akiskal, H.; Akiskal, K.; Figueira, M.L. The relationship between temperament, diabetes and depression. J. Affect. Disord. 2012, 142 Suppl, S67–71. [Google Scholar] [CrossRef]
- Bieliński, M.; Lesiewska, N.; Bielińska, J.; Liebert, A.; Mieczkowski, A.; Sopońska-Brzoszczyk, P.; Brzoszczyk, B.; Kłopocka, M.; Borkowska, A. Affective temperament in inflammatory bowel diseases: Another brick in the wall of differentiation. PLoS. One. 2018, 13, e0205606. [Google Scholar] [CrossRef]
- Borkowska, A.; Rybakowski, J.K.; Drozdz, W.; Bielinski, M.; Kosmowska, M.; Rajewska-Rager, A.; Bucinski, A.; Akiskal, K.K.; Akiskal, H.S. Polish validation of the TEMPS-A: the profile of affective temperaments in a college student population. J. Affect. Disord. 2010, 123, 36–41. [Google Scholar] [CrossRef] [PubMed]
- Akiskal, H.S.; Akiskal, K.K.; Haykal, R.F.; Haykal, R.F.; Manning, J.S.; Connor, P.D. TEMPS-A: progress towards validation of a self-rated clinical version of the temperament evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire. J. Affect. Disord. 2005, 85, 3–16. [Google Scholar] [CrossRef]
- Hlavaty, T.; Persoons, P.; Vermeire, S.; Ferrante, M.; Pierik, M.; Van Assche, G.; Rutgeerts, P. Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's disease. Inflamm. Bowel. Dis. 2006, 12, 199–204. [Google Scholar] [CrossRef] [PubMed]
- Vidal, A.; Gómez-Gil, E.; Sans, M.; Portella, M.J.; Salamero, M.; Piqué, J.M.; Panés, J. Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality. Inflamm. Bowel. Dis. 2008, 14, 977–983. [Google Scholar] [CrossRef] [PubMed]
- Sainsbury, A.; Heatley, R.V. Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 2005, 21, 499–508. [Google Scholar] [CrossRef] [PubMed]
- Janke, K.H.; Klump, B.; Gregor, M.; Meisner, C.; Haeuser, W. Determinant of life satisfaction in inflammatory bowel disease. Inflamm. Bowel. Dis. 2005, 11, 272–286. [Google Scholar] [CrossRef] [PubMed]
- Verma, S.; Tsai, H.H.; Giaffer, M.H. Does better disease-related education improve quality of life? A survey of IBD patients. Dig Dis Sci. 2001, 46, 865–9. [Google Scholar] [CrossRef] [PubMed]
- Lönnfors, S.; Vermeire, S.; Greco, M.; Hommes, M.; Bell, C.; Avedano, L. IBD and health-related quality of life -- discovering the true impact. J. Crohns. Colitis. 2014, 8, 1281–1286. [Google Scholar] [CrossRef] [PubMed]
- Karam, E.G.; Salamoun, M.M.; Yeretzian, J.S.; Mneimneh, Z.N.; Karam, A.N.; Fayyad, J.; Hantouche, E.; Akiskal, K.; Akiskal, H.S. The role of anxious and hyperthymic temperaments in mental disorders: a national epidemiologic study. World Psychiatry. 2010, 9, 103–10. [Google Scholar] [CrossRef] [PubMed]
- Moreno-Jiménez, B.; López Blanco, B.; Rodríguez-Muñoz, A.; Garrosa Hernández, E. The influence of personality factors on health-related quality of life of patients with inflammatory bowel disease. J. Psychosom. Res. 2007, 62, 39–46. [Google Scholar] [CrossRef] [PubMed]
- Perugi, G.; Toni, C.; Maremmani, I.; Tusini, G.; Ramacciotti, S.; Madia, A.; Fornaro, M.; Akiskal, H.S. The influence of affective temperaments and psychopathological traits on the definition of bipolar disorder subtypes: a study on bipolar I Italian national sample. J. Affect. Disord. 2012, 136, e41–9. [Google Scholar] [CrossRef]
- Roy, B.; Diez-Roux, A.V.; Seeman, T.; Ranjit, N.; Shea, S.; Cushman, M. Association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA). Psychosom. Med. 2010, 72, 134–140. [Google Scholar] [CrossRef] [PubMed]
- Cohen, S.; Doyle, W.J.; Turner, R.; Alper, C.M.; Skoner, D.P. Sociability and susceptibility to the common cold. Psychol. Sci. 2003, 14, 389–395. [Google Scholar] [CrossRef]
- Brydon, L.; Walker, C.; Wawrzyniak, A.J.; Chart, H.; Steptoe, A. Dispositional optimism and stress-induced changes in immunity and negative mood. Brain Behav. Immun. 2009, 23, 810–816. [Google Scholar] [CrossRef]
- Marrie, R.A.; Walld, R.; Bolton, J.M.; Sareen, J.; Walker, J.R.; Patten, S.B.; Singer, A.; Lix, L.M.; Hitchon, C.A.; El-Gabalawy, R.; Katz, A.; Fisk, J.D.; Bernstein, C.N.; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease. Increased incidence of psychiatric disorders in immune-mediated inflammatory disease. J. Psychosom. Res. 2017, 101, 17–23. [Google Scholar] [CrossRef] [PubMed]
- Nelson, B.W.; Byrne, M.L.; Simmons, J.G.; Whittle, S.; Schwartz, O.S.; O'Brien-Simpson, N.M.; Walsh, K.A.; Reynolds, E.C.; Allen, N.B. Adolescent temperament dimensions as stable prospective risk and protective factors for salivary C-reactive protein. Br. J. Health. Psychol. 2018, 23, 186–207. [Google Scholar] [CrossRef] [PubMed]
- Mikocka-Walus, A.; Ford, A.C.; Drossman, D.A. Antidepressants in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 2020, 17, 184–192. [Google Scholar] [CrossRef] [PubMed]
- Raedler, T. J. Inflammatory mechanisms in major depressive disorder. Curr. Opin. Psychiatry 2011, 24, 519–525. [Google Scholar] [CrossRef]
- O’Brien, S.M.; Scott, L.V.; Dinan, T.G. Antidepressant therapy and C-reactive protein levels. Br. J. Psychiatry 2006, 188, 449–452. [Google Scholar] [CrossRef] [PubMed]
| CD (n=55) | UC (n=61) |
IBD (n=116) |
||
| Mean age, range (Years) | 39 (19-69) |
46 (21-84) |
43 (19-84) |
|
| Male gender (, n (%)) | 24 (44%) |
31 (51%) |
55 (47%) |
|
| Mean BMI (kg/m2) | 23 (16-34) |
24.4 (14-37) |
23.87 (14-37) |
|
| Ongoing pharmacotherapy n (%) |
5-amino- ASA | 44 (80) | 59 (97) | 103 (89) |
| Azathiopryne | 26 (47) | 10 (16) | 36 (31) |
|
| Anty-TNF | 31 (56) | 4 (6) | 35 (30) |
|
| Medical history n (%) |
Relapses 0 1x 2-5 x >5 x |
6 (11) 11 (20) 27 (49) 11 (20) |
3 (5) 10 (16) 32 (52) 16 (26) |
10 (7) 21 (18) 58 (50) 27 (23) |
| Surgery* | 23 (42) | 7 (11) | 30 (26) | |
|
Disease duration <1 year <10 ys 10-20 ys >20 ys |
3 (5) 43 (78) 8 (14) 1 (2) |
1 (2) 43 (70) 8 (13) 9 (15) |
4 (3) 86 (74) 16 (14) 10 (9) |
|
| Mean scores IBDQ | IBD | CD | UC | Statistical significance |
|---|---|---|---|---|
| IBDQ bowel | 48.86 | 50 | 47.5 | p>0.05 |
| IBDQ emotion | 53 | 54 | 52.5 | p>0.05 |
| IBDQ systemic | 19.9 | 20,5 | 19.4 | p>0.05 |
| IBDQ social | 23.6 | 24 | 23 | p>0.05 |
| IBDQ total | 145 | 148.6 | 142.5 | p>0.05 |
| Mean scores | Median | Minimum | Maximum | SD | |
|---|---|---|---|---|---|
| TEMPS D | 0.39 | 0.33 | 0.05 | 0.95 | 0.18 |
| TEMPS-C | 0.42 | 0.38 | 0.00 | 1.00 | 0.25 |
| TEMPS-H | 0.41 | 0.38 | 0.05 | 0.95 | 0.20 |
| TEMPS-I | 0.23 | 0.22 | 0.00 | 0.80 | 0.18 |
| TEMPS-A | 0.387155 | 0.346154 | 0.00 | 1.00 | 0.24 |
| TEMPS-A ANXIOUS | TEMPS-A IRRITABLE |
TEMPS-A CYCLOTHYMIC | TEMPS-A DEPRESSIVE | TEMPS-A HYPERTHYMIC | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| F | Sig. | F | Sig. | F | Sig. | F | Sig. | F | Sig. | |
| bowel | 6.570 | .012 | 6.560 | .012 | 3.971 | .049 | 6.253 | .014 | .094 | .759 |
| emotional | 23.878 | .000 | 4.669 | .033 | 13.213 | .000 | 21.579 | .000 | .865 | .354 |
| systemic | 13.039 | .000 | 4.071 | .046 | 6.974 | .010 | 18.185 | .000 | 1.127 | .291 |
| social | 6.808 | .010 | 2.105 | .150 | 4.834 | .030 | 8.601 | .004 | .476 | .492 |
| IBDQ | 15.523 | .000 | 5.489 | .021 | 9.094 | .003 | 16.258 | .000 | .368 | .546 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
